Eric M. Yoshida
University of British Columbia · 604 works · 20,587 citations · h-index 62
Top works
- Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
- Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
- Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection
- ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis
- Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants
- Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
- Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial
- Fulminant liver failure during interferon beta treatment of multiple sclerosis
- Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment
- Primary biliary cirrhosis and inflammatory bowel disease.
- Choledochal cysts: part 1 of 3: classification and pathogenesis.
- Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials
- Concordance of sustained virological response 4, 12, and 24 weeks post‐treatment with sofosbuvir‐containing regimens for hepatitis C virus
- Asian Ethnicity–Related Differences in Gastric Cancer Presentation and Outcome Among Patients Treated at a Canadian Cancer Center
- Obstacles to Residentsʼ Conducting Research and Predictors of Publication
- Fatal reactivation of hepatitis B post-chemotherapy for lymphoma in a hepatitis B surface antigen-negative, hepatitis B core antibody-positive patient: Potential implications for future prophylaxis recommendations
- Does This Patient With Liver Disease Have Cirrhosis?
- Liver transplantation for chronic hepatitis B infection with the use of combination lamivudine and low-dose hepatitis B immune globulin
- Interferon-Based Combination Anti-Viral Therapy for Hepatitis C Virus After Liver Transplantation: A Review and Quantitative Analysis
- Liver transplantation for incidental cholangiocarcinoma: Analysis of the Canadian experience